Author:
Stanetić Kosana,Petrović Verica,Jatić Zaim,Stanetić Bojan,Kević Vesna,Stanetić Mirko,Matović Jelena,Marković Brankica
Abstract
Introduction: Benzodiazepines (BZD) are efficient drugs used to reduce anxiety, treat insomnia, or used as myorelaxants. BZDs are generally recommended for short-term use due to numerous side-effects and addiction. Objective: To investigate the prescribing pattern in family medicine outpatient clinics, in patients without the diagnosis of a mental disorder, and the influence of sociodemographic characteristics on BZD use. Method: A retrospective study of BZDs use, in a tenyear period (2009-2019), was conducted in patients treated in five family medicine teams of three primary health care centers in the Republic of Srpska. The study was carried out by reviewing electronic health records (EHRs) of patients above 18 years of age. The patients with the diagnosis of mental disorders were not recruited in the study. The study included 8560 EHRs, and 259 patients with the diagnosis of the mental disorders were excluded from the study. Results: Out of a total of 8301 analyzed EHRs, in 1044 (12.58%) patients at least one prescription for BZDs was found in a ten-year period. Females used BZDs in a greater percentage (71.07%), persons older than 65 years (44.54%), patients with secondary school education (60.44%), patients with chronic diseases (88.60%), patients living in an urban environment (75.96%). The most prescribed BZD was bromazepam (80.17%). Conclusion: The use of BZDs in our patients is quite considerable when compared to recommendations. The strategies to reduce BZD prescribing are necessary to reduce the chronic use of these drugs.
Publisher
Centre for Evaluation in Education and Science (CEON/CEES)
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference20 articles.
1. Mokhar A, Topp J, Härter M, Schulz H, Kuhn S, Verthein U, et al. Patientcentred care interventions to reduce the inappropriate prescription and use of benzodiazepines an z-drugs: a systematic review. PeerJ. 2018; 6:e5535. Doi: 10.7717/peerj.5535;
2. Clinical Guidelines for the Prescribing and Monitoring of Benzodiazepines and Related Medications. Available from https://dbhids.org/wp-content/uploads/2018/07/Clinical-Guidelinesfor-Prescribing-and-Monitoring-Benzodiazepines.pdf [cited 2020 Jun 20];
3. Kennedy KM, O'Riordan J. Prescribing benzodiazepines in general practice. Br J Gen Pract. 2019; 69:152-153. Doi: 10.3399/bjgp19X701753;
4. Bachhuber MA, Hennessy S, Cunningham CO, Starrels JL. Increasing benzodiazepine prescription and overdose mortality in the United States, 1996-2013. Am J Public Health. 2016; 106:686-688. Doi: 10.2105/AJPH.2016.303061;
5. Johansen ME, Niforatos JD. Benzodiazepine Use in the USA Is Driven by Long-term Users: a Repeated Crosssectional Study of MEPS 2002-2016. J Gen Intern Med. 2019;34:2717-19. doi: 10.1007/s11606-019-05042-2;